PWP
BIIB icon

Prasad Wealth Partners’s Biogen BIIB Stock Holding History

Prasad Wealth Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$266K Sell
1,450
-2
-0.1% -$369 0.07% 117
2025
Q4 		$256K Hold
1,452
– – 0.07% 121
2025
Q3 		$203K Buy
+1,452
New +$196K 0.06% 135
2025
Q1 		– Sell
-1,450
Closed -$222K – 117
2024
Q4 		$222K Buy
+1,450
New +$245K 0.07% 102

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Prasad Wealth Partners's BIIB Position: Q1 2026 in Review

Prasad Wealth Partners reduced its Biogen (BIIB) stake by 0.14% in Q1 2026, selling an estimated $369 and leaving 1,450 shares worth $266K. The position accounts for 0.07% of the portfolio, ranked #117.

Prasad Wealth Partners first reported a position in BIIB in Q4 2024 and has held it in 4 quarters since. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Prasad Wealth Partners held 1,450 shares of Biogen worth $266K as of Q1 2026.
  • Prasad Wealth Partners sold 2 Biogen shares in Q1 2026, an estimated $369.
  • Biogen made up 0.07% of Prasad Wealth Partners's portfolio in Q1 2026, its #117 holding.
  • Prasad Wealth Partners first reported a position in Biogen in Q4 2024 and has held it in 4 quarters since.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Prasad Wealth Partners's 13F filing for Q1 2026, filed 27 Apr 2026.